Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
DNTW18
|
|||
Drug Name |
SCO-120
|
|||
Indication | Breast cancer [ICD-11: 2C60-2C65; ICD-10: C50, C79.51] | Phase 1 | [1] | |
Company |
Sun Pharma Advanced Research Company
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT04242953) Study to Determine Safety, Tolerability and Pharmacokinetics, of SCO-120 in Healthy Male and Post-menopausal Female Subjects. U.S. National Institutes of Health. | |||
REF 2 | Clinical pipeline report, company report or official report of Sun Pharma Advanced Research Company. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.